Akums gets DCGI approval to launch Lobeglitazone for diabetes treatment in India EP News Bureau Feb 6, 2023 It offers a number of advantages including a higher safety profile, higher effectiveness in lower dosage, lower risk of…
In a first, Glenmark launches Lobeglitazone in India for uncontrolled type-II diabetes in adults EP News Bureau Oct 6, 2022 With this launch, the company aims to improve glycemic levels in uncontrolled diabetics and create a new pathway to treat insulin…